Armata Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Armata Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $17.5. The average 1-year stock price forecast is 147.18% higher than the current stock price, while the lowest is $15 (+111.86%) and the highest is $20 (+182.49%).

Price Target: $17.5 (+147.18%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$17.5	$17.5	$20
Change	+111.86%	+147.18%	+147.18%	+182.49%

Analyst Ratings

The average analyst rating for Armata Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	0	1	2	2	2	2
Buy	1	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Debanjana Chatterjee JonesTrading	JonesTrading	Buy Reiterates $20	Buy	Reiterates	$20	+182.49%	May 28, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $15	Buy	Reiterates	$15	+111.86%	May 14, 2026

Financial Forecast

Revenue This Year

2.20M

from 4.90M

-55.14%

from 4.90M

Revenue Next Year

2.75M

from 2.20M

25.00%

from 2.20M

EPS This Year

-0.82

from -1.31

EPS Next Year

-0.59

from -0.82

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.47M	5.51M	4.53M	5.17M	4.90M	2.20M
Revenue Growth	443.62%	23.11%	-17.77%	14.24%	-5.22%	-55.14%
Gross Profit	-15.54M	-29.51M	-29.24M	-20.85M	-10.81M	1.98M
Gross Margin	-347.36%	-535.75%	-645.64%	-403.02%	-220.49%	90.00%
Operating Income	-23.82M	-36.95M	-40.89M	-42.44M	-31.22M	-44.50M
Net Income	-23.16M	-36.92M	-69.05M	-18.92M	-173.80M	-171.90M
EPS	-	-	-	-	-1.31	-0.82
Free Cash Flow	-16.82M	-24.24M	-27.75M	-29.40M	-26.73M	82.80M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	3.6M
Avg	2.2M
Low	800,000

Revenue Growth

Revenue Growth	2026	2027	2028
High	-26.6%
Avg	-55.1%
Low	-83.7%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.82
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-